Cargando…
Suppression of Alzheimer's disease-related phenotypes by the heat shock protein 70 inducer, geranylgeranylacetone, in APP/PS1 transgenic mice via the ERK/p38 MAPK signaling pathway
HSP70 overexpression has a remedying effect in neurodegenerative diseases. In Alzheimer's disease (AD), the suppressive effects of HSP70 overexpression on AD-related phenotypes and the underlying mechanisms are unknown. In the current study, the effect of geranylgeranylacetone (GGA), a non-toxi...
Autores principales: | Sun, Yuan, Zhang, Jiang-Rong, Chen, Shuyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740803/ https://www.ncbi.nlm.nih.gov/pubmed/29285052 http://dx.doi.org/10.3892/etm.2017.5253 |
Ejemplares similares
-
Geranylgeranylacetone attenuates hepatic fibrosis by increasing the expression of heat shock protein 70
por: HE, WEI, et al.
Publicado: (2015) -
Induction of Heat-Shock Protein 70 Expression by Geranylgeranylacetone Shows Cytoprotective Effects in Cardiomyocytes of Mice under Humid Heat Stress
por: Wang, Xiaowu, et al.
Publicado: (2014) -
Suppression of Alzheimer’s Disease-Related Phenotypes by Geranylgeranylacetone in Mice
por: Hoshino, Tatsuya, et al.
Publicado: (2013) -
Protective effect of geranylgeranylacetone, an inducer of heat shock protein 70, against drug-induced lung injury/fibrosis in an animal model
por: Fujibayashi, Takayoshi, et al.
Publicado: (2009) -
Treatment with Geranylgeranylacetone Induces Heat Shock Protein 70 and Attenuates Neonatal Hyperoxic Lung Injury in a Model of Bronchopulmonary Dysplasia
por: Tokuriki, Shuko, et al.
Publicado: (2017)